Hundreds, perhaps thousands of previously unidentified functional small peptides could exist in most genomes, but these sequences have been generally overlooked. The discovery of genes encoding small peptides with important functions in different organisms, has ignited the interest in these sequences, and led to an increasing amount of effort towards their identification.
Identifying functional smORFs, a major challenge for genome annotations.
Deciphering the genetic information encoded in a genome is one of the main challenges in Biology. A constant improvement of sequencing and bioinformatics techniques has greatly advanced our understanding of this information but has also revealed the extent of its complexity. The difficulties associated with accurately predicting and annotating small Open Reading Frame genes (smORFs) perfectly illustrate this complexity and the challenges it poses.
In the genome of most organisms there are hundreds of thousands of putatively translated smORFs, consisting of a start-codon followed by in-frame codons and ending with a stopcodon [1] [2] . Distinguishing translated and functional smORFs among this overwhelming and mostly spurious pool of sequences represents a major issue, which is particularly difficult to resolve because standard computational algorithms to identify coding sequences are generally not suited for small sequences [3] [4] [5] . Initially, short coding sequences (<100 amino acids (aa)) were excluded from genome annotation pipelines [6] , with the assumption that the majority of coding genes would code for larger proteins [7] . However, genes encoding small peptides have been identified in several organisms [8] , such as the polycistronic tarsalless gene, which codes for 11 aa-long peptides with important developmental functions in arthropods [9] [10] [11] [12] . Such examples have led to the realisation that previously uncharacterised protein-coding smORFs with promising biological functions could exist in most genomes, and an increasing amount of effort has been directed towards their identification.
Here we will focus on the advances, both computational and biochemical, which have been used to identify smORFs, and will present some of the different examples of smORFs that have been functionally characterised as a consequence of these studies.
Altogether, there is evidence suggesting that smORFs form a substantial part of our genomes and that their encoded peptides could be involved in a variety of cellular functions. Their characterisation could therefore lead to discoveries with important implications in cell biology and human health.
Systematic searches for putative coding smORFs using computational approaches
Initial genome-wide searches for functional smORFs were conducted by bioinformatics methods designed to overcome the limitations of standard gene annotation algorithms.
Generally, these methods were based on the analysis of sequence-composition frequencies ( Figure 1A ; see sORFfinder and CRITICA in Box 1), and/or on the evaluation of: a) the conservation of candidate smORF sequences in related species using pair-wise alignmentbased tools ( Figure 1B ; BLAST [13] ), and b) of their purifying selection (conservation of the aa relative to nucleotide (nt) sequence) [14] . These initial studies identified several hundreds, and even thousands of putatively functional novel smORFs in the genomes of yeast, plants, flies, and mice [15] [16] [17] [18] [19] , generally representing about 3-5% of the annotated genes in these organisms ( Figure 2 ).
In order to identify conserved coding sequences, more recent methods based on multiple sequence alignments incorporate phylogenetic distances and a model of nt substitution rates, in the case of PhastCons [20] , or a model of codon substitution frequencies, in the case of phyloCSF [21] . Both are built upon known coding and non-coding sequences (see Box 1) . As shown later in this Review, these methods have sometimes been used together with experimental methods in order to validate, or strengthen, the functionality of the smORFs identified as translated.
Ribosome Profiling: a biochemical approach for genome-wide translation assessment of smORFs Next generation RNA sequencing (RNA-seq) has allowed the identification of entire transcriptomes [22] and has led to the unexpected realisation that a much higher than anticipated portion of the genome is transcribed (up to 85% in mammals [23] and 75% in flies [24] ). A large proportion of these transcripts lack a "long" ORF of more than 100 aa, and have therefore been considered as long non-coding RNAs (LncRNAs), even though they otherwise resemble canonical mRNAs, having a similar length, being transcribed by RNApolymerase II, capped, and poly-adenylated, and most even accumulating in the cytoplasm [25] . Although several LncRNAs have a well-established non-coding function [26] , for the vast majority this remains unknown, making it plausible that some LncRNAs actually encode smORFs.
A method known as ribosome profiling (or Ribo-Seq; Figure 1C ) [27] allows the quantitative and qualitative measurement of the translation of these transcriptomes. This method consists of sequencing nuclease-protected mRNA fragments (or footprints) bound by translating ribosomes stabilized with an elongation inhibitor such as cycloheximide (CHX) [28] .
Different ribosome profiling studies, in a wide variety of species [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , have found that translation occurs in an almost pervasive fashion. Ribosome footprints are detected in LncRNAs, in the untranslated regions (UTRs) of annotated transcripts either upstream (uORFs) or downstream (dORFs) of the coding DNA sequence (CDS), and even overlapping the CDS of canonical mRNAs, with the vast majority of these corresponding to short ORFs (Figures 2 and S2 ).
However there is some ambiguity with this method, since a ribosome protected fragment (RPF) read does not always strictly equate to an actively translated RNA fragment; a fragment of similar size could be obtained by a scanning ribosome, or other RNA-binding proteins [28] . Ribo-Seq studies therefore employ different experimental or computational strategies to identify more accurately actively translated regions, involving the use of different metrics, such as RPF coverage, translation efficiency (TE: the ratio of RPFs / total mRNA reads), ribosomal release score (RRS), or codon phasing (see Box 1, [2] ). Translation inhibitors, such as harringtonine (HR), which generate a pile-up of RPFs at the start codon, have also been used to identify translation initiation sites in actively translated ORFs [30] .
Unexpectedly, studies using this approach [27, 30, 33, 38, 41] , as well as some peptidomics studies [42] [43] , have shown that a considerable amount of translation, including that of many novel smORFs, initiates from non-canonical start codons, which increases the complexity of the proteome, and highlights the importance of biochemical detection methods to obtain comprehensive translation profiles. The sensitivity offered by Ribo-Seq, has allowed several studies to use this technique to identify translated smORFs in yeast [36] , fruit flies [32] , zebrafish [31] , mice [44] , and humans [33] .
In Drosophila, Aspden et al. [32] incorporated polysomal fractionation before Ribo-Seq to isolate cytoplasmic RNAs bound by 2-6 ribosomes. This selected for those RNAs being actively translated, rather than those being scanned by single non-productive ribosomes or other RNA-binding proteins, and also enriched for RNAs encoding short ORFs (6 ribosomes being the maximum number that could fit in a 300 nt ORF). Using stringent RPF density and coverage thresholds, they corroborated the translation of 83% of the annotated smORFs transcribed in Drosophila S2 cells (228 out of 274), and found 2,708 and 313 novel translated smORFs in 5'UTRs and LncRNAs, respectively (Figure 3 ). Annotated smORFs were found to be ~80 aa (median) and with similar levels of "functionality" as canonical coding genes (conservation, aa usage and secondary structures), whereas the smORFs detected in 5'UTRs and LncRNAs, were shorter (~20aa media length), and lacked the functional signatures observed in longer smORFs. However, some of these 5'UTR and LncRNA smORFs could be detected in epitope tagging experiments, displaying sub-cellular localizations similar to those of canonical proteins, suggesting that some of them may encode functional peptides.
In zebrafish embryos, Ribo-Seq profiles were analysed using ORFscore (See Box 2) [31] , a method that quantifies the 3-codon periodicity of the distribution of RPFs relative to the predicted ORF (phasing), a feature consistent with those ORFs being actively translated.
Using this method, they validated the translation of 302 (52%) previously annotated smORFs, and identified 190 novel smORFs in previously uncharacterised transcripts and LncRNAs, as well as 311 uORFs and 93 dORFs (Figures 2 and 3) . In parallel, 63 novel smORFs were found using a conservation-based computational pipeline (micPDP) (see Box 1) in a catalogue of non-coding transcripts, 23 of them were also deemed translated by Ribo-Seq, representing a pool of peptides highly likely to be translated and functional in zebrafish.
In yeast, 1,088 previously uncharacterised transcripts were found to associate with polyribosomes (supporting their translation) [36] . Ribo-Seq identified 185 of these as having sufficient footprint coverage and TE scores to support smORF translation. Furthermore, 61 out of 80 transcripts from this pool showed a codon triplet phasing bias to a single frame, suggesting their translation. Finally, 39 of these translated smORFs also showed varying extents of conservation among divergent yeast species, implying that they could be functional ( Figure 2 ).
In another study, human and mouse cell lines, were treated with lactimidomycin (LTM), another initiation phase inhibitor, prior to Ribo-Seq, in order to globally identify translation inititation sites [33] . 227 annotated Human smORFs were identified as translated (out of 694 of annotated smORFs in ENSEMBL), as well as 288 ORFs in LncRNAs and 1,194 uORFs (most of them <100 aa long) (Figures 2 and 3 ).
Altogether these studies show that thousands of smORFs are translated in eukaryotic genomes. A substantial number of smORFs exhibit conservation and coding potential features, suggesting that a large repertoire of functional, yet uncharacterized peptides could exist in these organisms.
Detection of smORF peptides by mass spectrometry
The high-performance Liquid chromatography tandem Mass-spectrometry (HPLC-MS/MS) proteomics approach has also been adapted to identify novel small peptides, by modifying, mainly, the protocols for data analysis. Here, instead of comparing candidate peptide spectrum matches (PSMs) to databases of annotated proteins, these are compared to databases generated de novo, based on all the possible translations of a given transcriptome ( Figure 1D ). Custom databases greatly increase the peptide spectra search space. This could potentially lead to higher rates of false positives, particularly since post-translational modifications, which have been shown to account for a substantial portion of unassigned HPLC-MS/MS spectra [45] , are not always taken into account, and could therefore lead to miss-identification of peptides.
One study identified 1,259 novel peptides by matching the spectra of 16 different HPLC-MS/MS data-sets from different human samples, to such a custom database, which included all possible alternative ORFs (mapping to UTRs and overlapping CDS') in the human transcriptome [46] ( Figure S2 ). This study suggests that the translation of these "alternative" smORFs could be a wide-spread phenomenon. Interestingly, the majority of these peptides were identified in plasma and serum samples (1,118 / 1,259), implying that they could be secreted, although the reason or mechanism leading to this remains unknown. Again, given the stochastic nature of this technique, this seemingly high number of identified novel peptides could be explained, in part, to the large number of samples analyzed in this study.
Another important consideration, is that standard proteomics require protein sequences to be supported by multiple PSMs. smORFs are often too short to fit more than one PSM; this single PSM should therefore be required to pass the most stringent criteria in order to be unambiguously assigned to that smORF. This higher stringency will reduce the rate of false positives, but may compromise the detection of bona-fide smORFs peptides. Slavoff et al.
[42] developed a peptidomics strategy, taking into account these analytical considerations, while also applying specific experimental optimizations. First, they inhibited proteolysis, arguing that the proteolytic fragments of canonical proteins greatly increase the complexity of the peptidome and deteriorate the signal to noise ratio when it comes to identifying short peptides; second, they used electrostatic-repulsion hydrophilic interaction chromatography (ERLIC) prior to HPLC-MS/MS. They identified 86 novel peptides in human cells: 33 of them mapping to alternative CDS' in annotated transcripts (corresponding to uORFs, dORFs, and smORFs overlapping annotated CDS'), 8 mapping to LncRNAs, and 49 of them mapping to previously un-annotated transcripts ( Figure 2 ).
This method was tested against other workflows [43] , leading to two important observations: first, the use of ERLIC fractionation greatly increases the number of peptides detected (~10 fold) and second, there is an important lack of overlap between the peptides identified by different workflows, and even by different technical repeats. This latter finding highlights the stochastic nature of this technique and the requirement of several repeats to achieve an optimal sampling saturation of the peptidome. In total, they analysed 3 different cell lines and a tumor sample, and identified a total of 311 short peptides, of which 237 are novel, with ~80% of them mapping to previously unannotated transcripts ( Figure S2 ). The rest map to alternative CDS within annotated transcripts with a similar distribution (in UTRs and overlapping CDS') as found by Slavoff et al. [42] .
Identification of smORFs by multiple approaches
In an attempt to more reliably identify translated smORFs, different studies have combined different computational and biochemical methods.
In one study, a computational smORF search was carried out in order to identify potentially coding smORFs in the mouse genome [44] , which were then compared to an available ribosome profiling dataset from a mouse cell line [30] . Putatively coding smORFs, conserved across mammalian species, were recovered using sORFinder [16] and PhastCons (Box 1).
Subsequently, a Support Vector Machine (SVM) learning algorithm, trained with sets of putatively non-coding and coding sequences, was used to classify the predicted smORFs, leading to the identification of 28, 471 smORFs with high coding probability in intergenic regions and LncRNAs. In parallel, they re-analysed the Ribo-Seq dataset, and identified 528 intergenic smORFs and 226 smORFs in LncRNAs, passing a coverage threshold and showing a pile-up at their start codon when treated with HR; of these, 401 and 89, respectively, were also found in the computational pipeline, representing a pool of smORFs likely to encode functional peptides ( Figure S2 ).
This study highlights the discrepancy in numbers that can exist between computational predictions and experimental detections. Part of this discrepancy could be explained on one hand by a possible high false positive rate in the bioinformatic pipeline, which could be due to, for example, to the presence of conserved elements such as transposons, pseudogenes, and simple repeats [47] . These false positive rates vary greatly among studies, depending on the stringency of filters applied in the computational pipelines. On the other hand, it could also be partly explained by the fact that computational pipelines search whole genomes for putative smORFs, whereas only the smORFs within transcripts expressed above a certain threshold in specific cells or tissues studied will be tested in experimental approaches.
Some of the Ribo-Seq-based studies covered above have used HPLC-MS/MS in order to validate their results (Figures 2 and S2 ). In general, previously annotated smORFs tend to be more abundantly detected by HPLC-MS/MS than uORFs or LncRNA smORFs; Aspden et al. [32] and Bazzini et al. [31] detected almost a third of the 228 and 302 annotated translated smORFs, respectively, but Aspden et al. [32] failed to identify any peptide from LncRNAs or uORFs, and Bazzini et al. [31] only identified 3 and 17 peptides, respectively.
Similarly, only a handful of peptides corresponding to uORFs and LncRNAs have been detected by HPLC-MS/MS in studies that detected hundreds by Ribo-Seq in humans [48] [49] ( Figures 2, S2 and 3) . These results clearly highlight a difference of sensitivity between these methods. They are also in agreement with the stochastic nature of peptidomics, observed by Slavoff et al. [42] , and with the shorter size and lower translation efficiency of LncRNA smORFs and uORFs observed by Aspden et al. [32] ; the peptides from LncRNAs or uORFs being generally smaller and probably less stable, and overall less abundant, have lower chances of being detected. In that sense, detection by peptidomics could be considered as a convincing proof of translation, and may indicate that the detected peptide is probably functional, provided that this detection is not the result of "translational noise" or a false positive; the absence of detection by peptidomics, however, should not be used to discard functionality ( Figure 3 ). It is also important to point out that these studies did not use the extensively optimized protocols (with proteolysis free conditions, ERLIC fractionation, and multiple technical repeats), which may have improved the detection rates of these smaller [32] in Drosophila, reinforcing the idea of functionally distinct classes of smORFs.
Computational and biochemical strategies lead to novel functional smORF peptides
Although these computational and biochemical approaches have identified hundreds of translated and conserved smORFs, previous systematic functional studies (based on random mutagenesis) in different organisms have failed to find them. This disparity could be explained by the lower probability of mutagens to target a small ORF in comparison to larger canonical ones. In addition, these small peptides may act as regulators of cellular processes requiring a very specific and in-depth analysis in order to detect their mutant phenotype. As a result, only a handful of smORFs, found serendipitously, had been functionally characterised prior to these extensive smORF searches [8] . Similarly, the Drosophila hemotin (hemo) gene was identified as a putative functional smORF by a computational study [17] , and its translation subsequently supported by ribosome profiling and proteomics studies [32, 58] (Figure 2) . hemo is expressed in hemocytes , showing that this regulatory mechanism is also conserved across evolution.
In humans, the 69 aa long MRI-2 peptide, was shown to stimulate double-strand break repair through a direct interaction with the DNA end binding protein Ku ( Figure 4C;[61] ).
This peptide was functionally characterized as a direct result of a HPLC-MS/MS screen for novel short peptides (Figure 2 ; [42] ) which detected it as translated in K562 cells.
These examples highlight the contribution of these bioinformatic and experimental approaches in the identification of functional smORFs. They also strengthen our view about the complexity and biological relevance of these peptides, which can regulate a diversity of cellular processes and are functionally conserved, in some cases, across vast evolutionary distances. Overall, their study can certainly have important implications in cell biology, and in human medical research [62] .
Concluding remarks and future perspectives
In this Review, we have shown extensive evidence supporting the translation of substantial numbers of smORFs in a variety of organisms. This evidence is likely to increase as new methods and metrics are developed to analyse Ribo-Seq data more robustly in order to identify bona fide translated regions, like, for example, the FLOSS and RiboTaper (See Box 2) methods: the former, based on the assessment of the organization of RPF lengths, specifically identifies the reads protected by translation-engaged ribosomes [41] ; the latter applies a spectral theory-based analytical method to identify the ribosome foot-print profiles across given transcripts that follow a tri-nucleotide periodicity and represent translated regions [48] . Other groups have used classification algorithms, such as the random forest-based Translated ORF classifier (TOC) [29, 57] , the logistic regression-based ORF-rater [63] , or the SVM-based RibORF [64] , which integrate different Ribo-Seq metrics, and their profiles on known coding and non-coding regions, to identify translated ORFs. All of these studies support the translation of hundreds of novel small peptides in vertebrates, encoded in transcripts previously thought to be non-coding or encoded as uORFs.
It remains challenging, however, to distinguish which among this ever-growing set of Ribo- [74] , and some uORFs have been shown to exert their regulatory function through their encoded peptides, with this regulation depending on their aa sequence [75] , and being able to occur in trans [76] [77] [78] [79] .
Systematic smORF searches have the ultimate aim of advancing genome annotations, which entails the attribution of specific functions to these newly detected smORFs. Although these studies, whether based on computational predictions, or experimental detection, by RiboSeq or Mass-spec or both, provide valuable information regarding the functional potential of smORFs, they remain elusive about their specific functions. This functional characterisation certainly poses the next challenge towards which an increased amount of effort should be directed.
Some general functional characteristics, like the segregation of smORFs into distinct functional classes, have been proposed [32] , and appear to be supported by the results of different studies [49] [50] , but these also remain to be tested through detailed phenotypic analysis. Advances in gene editing technologies such as CRIPSR, which allow one to relatively quickly generate specific mutants in most organisms [80] , and the development of more sensitive phenotypical screens and biochemical assays to accurately assess peptide functions [62], will help to start filling this void of functional information in the genome. Venn diagrams representing the number of smORFs detected by Ribo-Seq (blue) or HPLC-MS/MS (Mass spec, pink), relative to the total number of transcripts encoding each class of smORF (yellow) in humans [33, 42] , zebrafish [31] and fruit flies [32] . In these organisms, HPLC-MS/MS detects very few peptides from LncRNAs and uORFs (0%-0.3%), compared to annotated smORFs (12-33%), whereas Ribo-Seq still detects a substantial amount of LncRNA smORFs and uORFs (3-30%, compared to 30-80% annotated smORFs), highlighting the difference in sensitivity between these techniques. The number of transcribed uORFs (*)
was inferred from the number of transcripts with uORFs identified in other studies, for humans [65] and for zebrafish [29] ; the number of peptides identified in humans by HPLC-MS/MS ( †) were obtained from Mackowiak et al. [49] . The higher detection rates of annotated smORFs by HPLC-MS/MS could be due to their higher levels of expression and larger (and more stable) peptides, which also correlate with their closer resemblance to canonical proteins in terms of functional signatures (protein domain content, conservation).
Although these observations imply that annotated smORFs represent a functionally distinct class from LncRNA smORFs and uORFs, the identification of a growing number of biologically active peptides encoded in previously non-coding RNAs and uORFs (italics) proves that their functionality should not be systematically discarded. sORF finder: bioinformatic package to identify smORFs with high confident coding potential based on their similarity in nucleotide composition to bona fide coding genes by hidden Markov model. Potential coding smORFs are further tested for functionality by searching homologues and evolutionary constrains [16] .
Coding Region Identification Tool Invoking Comparative Analysis (CRITICA): gene prediction algorithm that intergrates a purifying selection analysis of pair-wise aligned homologous regions into a hexamere sequence composition-analysis [18] .
PhastCons: program that predicts conserved elements in multiple alignment sequences. It is based on a statistical hidden Markov phylogenetic model (phylo-HMM) that takes into account the probability of nucleotide substitutions at each site in a genome and how this probability changes from one site to the next [20] .
PhyloCSF: comparative sequence method that analyses multiple alignments of nucleotide sequence using statistical comparison of phylogenetic codon models to ascertain the likelihood to be a conserved protein coding sequence [21] .
Micropeptide detection pipeline (micPDP): method that evaluates the existence of purifying selection on aa sequence from codon nucleotide changes. This pipeline filters candidate alignments according to coverage and reading frame conservation and then the PhyloCSF method is applied to assess their coding potential from codon substitutions in genome-wide multi-alignments [31] .
Coding Potential Calculator (CPC): bioinformatics tool that scores six sequence features to distinguish coding vs non-coding ORFs. Three of the features relate to the quality of the longest ORF (ORF size, Coverage, integrity) whereas the other three are based on sequence conservation using BLASTX (number of hits, quality of the hits, frame distribution of hits) that are incorporated in a Support Vector learning machine classifier. [81] [82] .
BOX-2. Evaluation of smORF-coding potential and translation by Ribosomal profiling methods.
ORFscore: translation-dependent metric that exploits the 3nt step movement of translating ribosomes across the transcript. Therefore, the Ribo-Seq reads in coding ORFs tend to show a tri-nucleotide periodicity on the frame of translation (phasing) [31] . This method requires a restricted sample of RPFs, with sizes matching the more abundant average ribosomal footprint, usually 28-29nt.
Ribosome Release Score (RRS): metric defined as the ratio between the total number of Ribo-Seq reads in the ORF and the total number Ribo-Seq reads in the subsequent 3'UTR, normalized respectively to the total length of their regions divided by the normalized number of RNA-Seq reads in each region computed in the same fashion [83] .
Fragment length organisation similarity score (FLOSS): this method relies on the difference of RPF length distribution between coding genes and non-coding RNAs. This metric scores the coding potential of ORFs according to the similarity between their RPF length distribution, and that of known coding genes [41] .
Translated ORF Classifier (TOC): Random Forest classifier that assesses the ORF-coding potential within a transcript according to 4 metrics: Translation Efficiency (ratio of the RiboSeq reads/RNA-Seq read within the ORF), Inside vs Outside (coverage inside ORF/coverage outside ORF; coverage: nucleotides having Ribo-Seq reads/total number of nucleotides), Fraction Length (fraction of the transcript covered by ORF) and Disengagement score (DS) (assesses the efficiency of ribosomal release after a stop codon). [29] . Pauli et al. [57] improved the TOC by adding a "coverage" metric.
ORF Regression Algorithm for Translational Evaluation of RPFs (ORF-RATER):
this metric quantifies the translation of ORFs from Ribo-Seq data by comparing the patterns of ribosome occupancy (initiation and termination peaks and elongation phase) to that of coding ORFs. ORF-RATER uses a linear regression model that allows the integration of multiple lines of evidence and evaluates each ORF according to the nearby context [63] .
RibORF Classifier: a Support Vector Machine classifier that defines active translation of ORFs based on the evaluation of phasing parameters obtained from canonical proteins. This method identifies 3-nt periodicity, and uniformity of footprint distribution across codons by calculating the percentage of maximum entropy values [64] .
RiboTaper: Similar to ORFscore but uses a multitaper spectral analysis method to obtain 3nt periodicity from raw Ribo-Seq read data, which is typically noisy. This allows to calculate framing patterns using reads of varied lengths, provided that the P-site position is determined for each length [48] .
